Finally, we combined α-MG and AKT inhibitor MK2206 for treating tumor cells and found that the suppressed periFN assembly was restored (Figure 3E), suggesting that α-MG suppresses periFN assembly on suspended tumor cells via enhanced AKT activity. This evidence concerns the gene AKT1 and neoplasm.